17th Community Wide Experiment on the
Critical Assessment of Techniques for Protein Structure Prediction
Target List csv
Targets are released at 9:30 am Pacific time (PDT=GMT-7hours) and expire at 9:00 am PDT.

Predictions in special categories, where a large number of models is requested, should be submitted before the Soft Deadline (typically 2 days before the Human Expiration) as submissions in these categories will not be checked immediately upon acceptance, but shortly afterwards. If model(s) have formatting issues, you will get a message from us within a few hours after the Soft Deadline so that you will have a chance to resubmit models before the Human Expiration deadline.

Green color - active target; Yellow color - target expires within 48 hours; Orange color - target expires within 24 hours
Nucleic acid-containing complexes are highlighted with the light grey background.

Target type 'h' is for human targets, 's' for server-only targets.
Target naming convention: Txxxx - protein monomers/homomers; Hxxxx - protein heteromers; Rxxxx - RNA monomers/homomers; Dxxxx - DNA monomers/homomers; Mxxxx (hybrid) - nucleic acid-containing hetero-complexes (with or without protein); Lxxxx - ligand only targets.
Stoichiometry 'UNK' stands for UNKNOWN.
* CAPRI target

All targets Mono/Homo -mers Multimers RNA Ligand Ensemble
Phase 1 | 2 | all Phase 1 | 2 | all Phase 1 | 2 | all Phase 1 | 2 | all
#
Tar-id
Type
Res
Stoichiom.
Entry    
Date
Server
Expiration
Soft
Deadline
Human
Expiration
QA
Prediction
Description
1. R2301 s NucA 96 A1 2026-04-27 2026-04-29 2026-04-29 2026-04-29 - Eterna JR_UC2199_030
2. R2302 s NucA 90 A1 2026-04-27 2026-04-29 2026-04-29 2026-04-29 - Eterna PK90_14 f39
3. R2303 s NucA 84 A2 2026-04-28 2026-04-30 2026-04-30 2026-04-30 - Eterna ZG_113_EliFisker_F_10
4. R2304 s NucA 100 A1 2026-04-28 2026-04-30 2026-04-30 2026-04-30 - Struct2SeQ SHAPE design
PDB code 11eh
5. R2305 s NucA 105 A2 2026-04-29 2026-05-01 2026-05-01 2026-05-01 - MPNN-RFdiff design
PDB code 11ag
6. R2306 s NucA 100 A1 2026-04-29 2026-05-01 2026-05-01 2026-05-01 - MPNN-fixbb design
PDB code 10zu
7. R2307 s NucA 100 A1 2026-04-30 2026-05-02 2026-05-02 2026-05-02 - gRNAde design
PDB code 10zt
8. R2308 s NucA 93 A1 2026-04-30 2026-05-02 2026-05-02 2026-05-02 - Triphosphorylation ribozyme
9. M2310 s Hybrid /Ensmbl 810 A1B1 2026-05-01 2026-05-05 2026-05-05 2026-05-05 - B.a. group IIB2 intron postcat
10. R2309 s NucA /Ensmbl 810 A1 2026-05-01 2026-05-05 2026-05-05 2026-05-05 - B.a. group IIB2 intron precat
11. R2310 s NucA /Ensmbl 788 A1 2026-05-01 2026-05-05 2026-05-05 2026-05-05 - B.a. group IIB2 intron postcat
12. R2314 s NucA/Ligand /Ensmbl 25 A1 2026-05-04 2026-05-06 2026-05-06 2026-05-06 - Tryptophan binding aptamer holo
13. R2315 s NucA /Ensmbl 25 A1 2026-05-04 2026-05-06 2026-05-06 2026-05-06 - Tryptophan binding aptamer apo
14. R2316 s NucA 97 A1 2026-05-04 2026-05-06 2026-05-06 2026-05-06 - miniTTR GNRA tetraloop/receptor
15. R2317 s NucA/Ligand 129 A1 2026-05-05 2026-05-07 2026-05-07 2026-05-07 - Lmo Glycine riboswitch holo
16. R2318 s NucA/Ligand 140 A1 2026-05-05 2026-05-07 2026-05-07 2026-05-07 - Dha Glycine riboswitch holo
17. M2320 s Hybrid 731 A1B1 2026-05-06 2026-05-10 2026-05-10 2026-05-10 - C.tet group IIB intron
18. R2320s0 s NucA 731 A1 2026-05-06 2026-05-10 2026-05-10 2026-05-10 - C.tet group IIB intron
19. H2324 * h Prot 856 A1B1C1D1E1 2026-05-07 2026-05-10 2026-05-21 2026-05-21 from: 2026-05-21
to: 2026-05-24
T Cell Receptor N17.2, complex (5 chains)
PDB code 9yw4
20. R2322 s NucA /Ensmbl 83 A1 2026-05-07 2026-05-09 2026-05-14 2026-05-14 - RNA - miniTTR-11 monomer mutant
21. R2323 s NucA /Ensmbl 83 A2 2026-05-07 2026-05-09 2026-05-14 2026-05-14 - RNA - miniTTR-11 WT
22. R2325 s NucA 499 A2 2026-05-08 2026-05-11 2026-05-11 2026-05-11 - O.i. group II intron dimer
23. R2326 s NucA/Ligand 37 A1 2026-05-11 2026-05-13 2026-05-13 2026-05-13 - Arginine binding aptamer
24. R2327 s NucA/Ligand 40 A1 2026-05-11 2026-05-13 2026-05-13 2026-05-13 - Histidine binding aptamer
25. R2328 s NucA/Ligand 32 A1 2026-05-11 2026-05-13 2026-05-13 2026-05-13 - Isoleucine binding aptamer
26. R2329 s NucA/Ligand 60 A1 2026-05-12 2026-05-14 2026-05-14 2026-05-14 - SAMURI ribozyme holo
27. R2330 s NucA/Ligand 75 A1 2026-05-12 2026-05-14 2026-05-14 2026-05-14 - TPP riboswitch holo
28. H2312 * h Prot 1409 A1B1C1 2026-05-13 2026-05-16 2026-05-27 2026-05-27 from: 2026-05-27
to: 2026-05-30
EXT1-EXT2-2BAV4
29. M2333 s Hybrid 614 A1B1 2026-05-13 2026-05-15 2026-05-15 2026-05-15 - TaitIntron RNA
30. R2333s0 s NucA /Ensmbl 614 A1 2026-05-13 2026-05-15 2026-05-15 2026-05-15 - TaitIntron RNA
31. H2338 * h Prot 1050 A1B1C1D1 2026-05-14 2026-05-17 2026-05-21 2026-05-29 from: 2026-05-29
to: 2026-06-01
Factor XIa antibody complex 9933
PDB code 9yrq
32. M2334 s Hybrid 1204 A1B1 2026-05-14 2026-05-16 2026-05-16 2026-05-16 - TaitIntron RNP
33. R2334 s NucA /Ensmbl 609 A1B1 2026-05-14 2026-05-16 2026-05-16 2026-05-16 - TaitIntron RNP
34. T2313 * h Prot 618 A3 2026-05-14 2026-05-17 2026-05-28 2026-05-28 from: 2026-05-28
to: 2026-05-31
P66
35. H2339 * h Prot 1044 A1B1C1D1 2026-05-15 2026-05-18 2026-05-22 2026-05-30 from: 2026-05-30
to: 2026-06-02
Factor XIa antibody complex 7508
PDB code 9yrb
36. M2337 s Hybrid 644 A1B1 2026-05-15 2026-05-18 2026-05-22 2026-05-22 - Pli Group IIB intron postcat
37. R2336 s NucA /Ensmbl 644 A1 2026-05-15 2026-05-18 2026-05-22 2026-05-22 - Pli Group IIB intron precat
38. R2337s0 s NucA /Ensmbl 644 A1 2026-05-15 2026-05-18 2026-05-22 2026-05-22 - Pli Group IIB intron postcat
39. R2341 h NucA 186 A1 2026-05-18 2026-05-20 2026-06-01 2026-06-01 from: 2026-06-01
to: 2026-06-04
RRE core
40. H2319 * h Prot 497 A2B2C2 2026-05-19 2026-05-22 2026-06-02 2026-06-02 from: 2026-06-02
to: 2026-06-05
Human astrovirus VA1 capsid spike - antibody 7C8 complex
PDB code 9oef
41. H2321 * h Prot 502 A2B2C2 2026-05-20 2026-05-23 2026-06-03 2026-06-03 from: 2026-06-03
to: 2026-06-06
Human astrovirus VA1 capsid spike - antibody 2A2 complex
PDB code 9oeg
42. R2345 s NucA 64 A1 2026-05-21 2026-05-23 2026-06-04 2026-06-04 - R10C03
43. R2350 h NucA 389 A1 2026-05-25 2026-05-27 2026-06-06 2026-06-08 from: 2026-06-08
to: 2026-06-11
Tetrahymena Ribozyme C7.2 mutant RNA
44. R2351 h NucA 389 A1 2026-05-26 2026-05-28 2026-06-07 2026-06-09 from: 2026-06-09
to: 2026-06-12
Tetrahymena Ribozyme R1 mutant RNA
45. H2335 * h Prot 1820 A1B1C1D1E1 2026-05-27 2026-05-30 2026-06-10 2026-06-10 from: 2026-06-10
to: 2026-06-13
HCMV Merlin gHgLgO-Fab complex
46. R2352 h NucA 389 A1 2026-05-27 2026-05-29 2026-06-08 2026-06-10 from: 2026-06-10
to: 2026-06-13
Tetrahymena Ribozyme IC3 mutant RNA
47. R2353 h NucA 394 A1 2026-05-28 2026-05-30 2026-06-09 2026-06-11 from: 2026-06-11
to: 2026-06-14
Tetrahymena Ribozyme Vc2 mutant RNA
48. H2340 * h Prot 686 A3B3C3 2026-06-01 2026-06-04 2026-06-15 2026-06-15 from: 2026-06-15
to: 2026-06-18
Parahenipavirus F protein /antibody complex
49. H2343 * h Prot 773 A1B1C1 2026-06-01 2026-06-04 2026-06-15 2026-06-15 from: 2026-06-15
to: 2026-06-18
Hepatitis C Virus sE2 CBH-4G Fab complex
50. R2365 h NucA/Ligand 60 A1 2026-06-01 2026-06-04 2026-06-13 2026-06-15 from: 2026-06-15
to: 2026-06-18
RNA-GTP complex
51. E2366 h Prot /Ensmbl 1269 A3 2026-06-02 2026-06-09 2026-07-14 2026-07-16 - S-PRD0038-WT
52. E2367 h Prot /Ensmbl 1269 A3 2026-06-02 2026-06-09 2026-07-14 2026-07-16 - S-PRD0038-D603G
53. T2342 * h Prot 1455 A3 2026-06-02 2026-06-05 2026-06-16 2026-06-16 from: 2026-06-16
to: 2026-06-19
Spike glycoprotein ectodomain
54. E2368 h Prot /Ensmbl 1269 A3 2026-06-03 2026-06-10 2026-07-15 2026-07-17 - S-PRD0038-Q617K
55. E2369 h Prot /Ensmbl 1269 A3 2026-06-03 2026-06-10 2026-07-15 2026-07-17 - S-PRD0038-D603G-Q617K
56. H2344 * h Prot 734 A1B1C1 2026-06-03 2026-06-06 2026-06-17 2026-06-17 from: 2026-06-17
to: 2026-06-20
HSV gD - HAB72
57. H2346 * h Prot 885 A1B1C1D1 2026-06-04 2026-06-07 2026-06-18 2026-06-18 from: 2026-06-18
to: 2026-06-21
REGN3753 Fab-Fab complex
58. H2347 * h Prot 876 A1B1C1D1 2026-06-04 2026-06-07 2026-06-18 2026-06-18 from: 2026-06-18
to: 2026-06-21
REGN15499 Fab-Fab complex
59. H2348 * h Prot 1034 A1B1C1 2026-06-05 2026-06-08 2026-06-19 2026-06-19 from: 2026-06-19
to: 2026-06-22
gp130 antibody complex
60. H2349 * h Prot 1030 A1B1C1 2026-06-05 2026-06-08 2026-06-19 2026-06-19 from: 2026-06-19
to: 2026-06-22
gp130 antibody complex
61. H2354 * h Prot 726 A3B3C3 2026-06-08 2026-06-11 2026-06-22 2026-06-22 from: 2026-06-22
to: 2026-06-25
hemagglutinin/antibody
62. H2355 * h Prot 708 A3B3C3 2026-06-08 2026-06-11 2026-06-20 2026-06-22 from: 2026-06-22
to: 2026-06-25
hemagglutinin/antibody
63. E2375 h Prot /Ensmbl 668 A3B3 2026-06-09 2026-06-16 2026-07-21 2026-07-23 - HIV-1 envelope protein complex B37B
64. E2376 h Prot /Ensmbl 662 A3B3 2026-06-09 2026-06-16 2026-07-21 2026-07-23 - HIV-1 envelope protein complex B42A
65. H2356 h Prot 590 A8B4 2026-06-09 2026-06-12 2026-06-21 2026-06-23 from: 2026-06-23
to: 2026-06-26
A0A517IGU2, A0A517I5H8
66. H2359 * h Prot 2336 A1B1C1D1E1F1 2026-06-10 2026-06-13 2026-06-22 2026-06-24 from: 2026-06-24
to: 2026-06-27
A0AB35JLN2, A0AAE5SBF7, A0A2S4JD57, A0A0Q0BBX2, A0A1A6E3L8, A0ABT2VBN8
67. T2358 s Server only 151 A2 2026-06-10 2026-06-13 2026-06-13 2026-06-13 - A7XXF0_BP234
68. H2360 * h Prot 1558 A1B1C1D1E1 2026-06-11 2026-06-14 2026-06-23 2026-06-25 from: 2026-06-25
to: 2026-06-28
P69905, P68871
69. H2362 * h Prot 1836 A1B1C1D1E1F1G1 2026-06-12 2026-06-15 2026-06-24 2026-06-26 from: 2026-06-26
to: 2026-06-29
HCMV with a FAB
70. T2383 s Server /Ligand 1142 A1 2026-06-12 2026-06-15 2026-06-24 2026-06-26 - DNA damage-binding protein
71. W2385 h /Ensmbl 417 A1 2026-06-12 2026-06-19 2026-07-24 2026-07-26 - Group IIC Intron
72. W2386 h /Ensmbl 417 A1 2026-06-12 2026-06-19 2026-07-24 2026-07-26 - Group IIC Intron
73. R2387 h NucA/Ligand 43 A1 2026-06-15 2026-06-17 2026-06-27 2026-06-29 from: 2026-06-29
to: 2026-07-02
RNA-NAD+ complex
74. T2364 h Prot 86 A3 2026-06-15 2026-06-18 2026-06-29 2026-06-29 from: 2026-06-29
to: 2026-07-02
A0A178UXU6
75. R2390 h NucA/Ligand 34 A1 2026-06-17 2026-06-19 2026-06-29 2026-07-01 from: 2026-07-01
to: 2026-07-04
RNA-NMN complex
76. T2395 h Prot 176 A5 2026-06-18 2026-06-21 2026-06-30 2026-07-02 from: 2026-07-02
to: 2026-07-05
Ab CSUA1 Fiber
77. T2371 * h Prot 151 A2 2026-06-19 2026-06-22 2026-07-03 2026-07-03 from: 2026-07-03
to: 2026-07-06
Q8TW57
78. H2373 * h Prot 725 A1B1C1 2026-06-22 2026-06-25 2026-07-06 2026-07-06 from: 2026-07-06
to: 2026-07-09
HSV-2 gD - HAB194
79. H2374 * h Prot 739 A1B1C1 2026-06-22 2026-06-25 2026-07-06 2026-07-06 from: 2026-07-06
to: 2026-07-09
HSV-2 gD - HAB13
80. M2377v1 h Hybrid /Ensmbl 462 A2B1 2026-06-24 2026-06-27 2026-07-08 2026-07-08 from: 2026-07-08
to: 2026-07-11
P15692-4 / 2XP
81. M2377v2 h Hybrid /Ensmbl 462 A2B1 2026-06-24 2026-06-27 2026-07-08 2026-07-08 from: 2026-07-08
to: 2026-07-11
P15692-4 / 2XP
82. R2377v1 h NucA /Ensmbl 276 A1 2026-06-24 2026-06-27 2026-07-08 2026-07-08 from: 2026-07-08
to: 2026-07-11
P15692-4 / 2XP
83. R2377v2 h NucA /Ensmbl 276 A1 2026-06-24 2026-06-27 2026-07-08 2026-07-08 from: 2026-07-08
to: 2026-07-11
P15692-4 / 2XP
84. H2379 * h Prot 697 A3B3C3 2026-06-25 2026-06-28 2026-07-09 2026-07-09 from: 2026-07-09
to: 2026-07-12
MeV F + Fab1
85. H2380 * h Prot 693 A2B2C2 2026-06-25 2026-06-28 2026-07-09 2026-07-09 from: 2026-07-09
to: 2026-07-12
MeV H + Fab1
86. H2381 * h Prot 704 A3B3C3 2026-06-26 2026-06-29 2026-07-10 2026-07-10 from: 2026-07-10
to: 2026-07-13
MeV F + Fab2
87. H2382 * h Prot 700 A2B2C2 2026-06-26 2026-06-29 2026-07-10 2026-07-10 from: 2026-07-10
to: 2026-07-13
MeV H + Fab2
88. T2396 s Server only 239 A5 2026-06-27 2026-06-30 2026-06-30 2026-06-30 - Atlas-Nbr capsid
89. T2397 s Server only 244 A5 2026-06-27 2026-06-30 2026-06-30 2026-06-30 - Atlas virus capsid (Pao retrotransposon), GenBank:EPB78661
90. H2388 * h Prot 244 A1B1 2026-06-29 2026-07-02 2026-07-13 2026-07-13 from: 2026-07-13
to: 2026-07-16
14-3-3 gamma bound to LARP1 derived phosphopeptide
91. H2408 * h Prot 1138 A1B1C1 2026-06-29 2026-07-02 2026-07-11 2026-07-13 from: 2026-07-13
to: 2026-07-16
COQ3-COQ6-L2HGDH ternary complex
92. H2389 * h Prot 702 A3B1C1 2026-06-30 2026-07-03 2026-07-14 2026-07-14 from: 2026-07-14
to: 2026-07-17
MeV F + Fab3
93. H2391 * h Prot 702 A3B3C3 2026-06-30 2026-07-03 2026-07-14 2026-07-14 from: 2026-07-14
to: 2026-07-17
MeV F + Fab4
94. T2409 h Prot /Ligand 472 A1 2026-06-30 2026-07-03 2026-07-16 2026-07-18 - Amidase with UO4
95. T2410 h Prot /Ligand 472 A1 2026-06-30 2026-07-03 2026-07-16 2026-07-18 - Amidase with CID 343975
96. H2392 * h Prot 707 A2B1C1 2026-07-01 2026-07-04 2026-07-15 2026-07-15 from: 2026-07-15
to: 2026-07-18
MeV H + Fab3
97. T2393 * h Prot 576 A2 2026-07-01 2026-07-04 2026-07-15 2026-07-15 from: 2026-07-15
to: 2026-07-18
GLE_4604
98. T2411 h Prot /Ligand 472 A1 2026-07-01 2026-07-04 2026-07-17 2026-07-19 - Amidase with U08
99. T2412 h Prot /Ligand 225 A1 2026-07-01 2026-07-04 2026-07-17 2026-07-19 - SETDB1-ligand complex
100. H2394 * h Prot 566 A3B3C3 2026-07-02 2026-07-05 2026-07-16 2026-07-16 from: 2026-07-16
to: 2026-07-19
LujoGP+Fab8
101. T2413 h Prot /Ligand 274 A1 2026-07-02 2026-07-05 2026-07-18 2026-07-20 - PIM kinase with inhibitor
102. T2414 h Prot /Ligand 324 A1 2026-07-02 2026-07-05 2026-07-18 2026-07-20 - KIT kinase with inhibitor
103. M2415 h Prot-NucA/Ligand 1231 A1B1C1D1E1F1G1H1I1J1K1L1 2026-07-03 2026-07-07 2026-07-23 2026-07-25 from: 2026-07-25
to: 2026-07-28
U1 snRNP with ligand
104. R2415s0 h NucA 1231 A1 2026-07-03 2026-07-07 2026-07-23 2026-07-25 - U1 snRNP with ligand
105. H2398 * h Prot 570 A1B1C1 2026-07-06 2026-07-09 2026-07-18 2026-07-20 from: 2026-07-20
to: 2026-07-23
LujoGP+Fab9
106. H2399 * h Prot 568 A1B1C1 2026-07-06 2026-07-09 2026-07-18 2026-07-20 from: 2026-07-20
to: 2026-07-23
LujoGP+Fab10
107. R2425 s NucA 851 A1 2026-07-06 2026-07-08 2026-07-08 2026-07-08 - B.cI4 precat
108. H2400 * h Prot 572 A1B1C1 2026-07-07 2026-07-10 2026-07-19 2026-07-21 from: 2026-07-21
to: 2026-07-24
LujoGP+Fab11
109. H2401 * h Prot 572 A1B1C1 2026-07-07 2026-07-10 2026-07-19 2026-07-21 from: 2026-07-21
to: 2026-07-24
LujoGP+Fab12
110. R2426 s NucA 851 A1B1 2026-07-07 2026-07-09 2026-07-09 2026-07-09 - B.cI4 postcat
111. H2402 * h Prot 579 A1B1C1 2026-07-08 2026-07-11 2026-07-20 2026-07-22 from: 2026-07-22
to: 2026-07-25
LujoGP+Fab13
112. H2403 * h Prot 568 A1B1C1 2026-07-08 2026-07-11 2026-07-20 2026-07-22 from: 2026-07-22
to: 2026-07-25
LujoGP+Fab14
113. R2427 s NucA 604 A1 2026-07-08 2026-07-10 2026-07-10 2026-07-10 - S.maI1 precat
114. R2428 s NucA 87 A1 2026-07-09 2026-07-11 2026-07-11 2026-07-11 - BISPR RNA motif
115. T2404 h Prot 263 A17 2026-07-09 2026-07-12 2026-07-21 2026-07-23 from: 2026-07-23
to: 2026-07-26
Cap19
116. T2406 * h Prot 479 A2 2026-07-10 2026-07-13 2026-07-22 2026-07-24 from: 2026-07-24
to: 2026-07-27
C0V70_15230
117. H2422 s Server only 586 A2B2 2026-07-13 2026-07-16 2026-07-16 2026-07-16 - SlpA
118. H2423 s Server only 591 A2B2 2026-07-13 2026-07-16 2026-07-16 2026-07-16 - SlpA4del
119. R2429 h NucA 345 A1 2026-07-20 2026-07-22 2026-08-03 2026-08-03 from: 2026-08-03
to: 2026-08-06
PIE-V1
120. T2416 * h Prot 414 A3 2026-07-20 2026-07-23 2026-08-03 2026-08-03 from: 2026-08-03
to: 2026-08-06
CotH
121. T2417 * h Prot 249 A3 2026-07-20 2026-07-23 2026-08-03 2026-08-03 from: 2026-08-03
to: 2026-08-06
APR53_05355
122. E2446 h Prot /Ensmbl 107 A1 2026-07-21 2026-07-28 2026-08-18 2026-08-18 - BhR2
123. H2419 * h Prot 654 A1B1C1 2026-07-21 2026-07-24 2026-08-04 2026-08-04 from: 2026-08-04
to: 2026-08-07
SARS-CoV-2 spike (P0DTC2) RBD in complex with mAb
124. E2447 h Prot /Ensmbl 97 A1 2026-07-22 2026-07-29 2026-08-19 2026-08-19 - pat90
125. T2421 h Prot 178 A3 2026-07-22 2026-07-25 2026-08-05 2026-08-05 from: 2026-08-05
to: 2026-08-08
YP_007379091.1
126. A2445 h /Ensmbl 456 A1 2026-07-23 2026-07-30 2026-08-22 2026-08-22 - Group IIC Intron scaffold with SAMURI
127. E2448 h Prot /Ensmbl 139 A1 2026-07-23 2026-07-30 2026-08-20 2026-08-20 - SR215
128. E2449 h Prot /Ensmbl 92 A1 2026-07-24 2026-07-31 2026-08-21 2026-08-21 - StR82
129. H2424 * h Prot 2364 A3B3C6D18E3F3 2026-07-24 2026-07-27 2026-08-05 2026-08-07 from: 2026-08-07
to: 2026-08-10
9NA bacteriophage baseplate
Protein Structure Prediction Center
Sponsored by the US National Institute of General Medical Sciences (NIH/NIGMS)
Please address any questions or queries to:
© 2007-2026, University of California, Davis
Terms of Use